Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof

Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof

US Patent 11472889 · Granted Oct 18, 2022

Estimated economic value: $926,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Proteins comprising CD3 antigen binding domains and uses thereof2025
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
HER-2 targeted bispecific compositions and methods for making and using the same2025
Protease-resistant systems for polypeptide display and methods of making and usi2024
Proteins comprising CD3 antigen binding domains and uses thereof2024
Proteins comprising kallikrein related peptidase 2 antigen binding domains and t2024
Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use2024
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2024
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2024